Amar is an Operating Principal at Khosla Ventures where he focuses on life science companies. He is particularly interested in advanced therapeutic modalities, platforms for drug discovery and delivery, and the applications of synthetic biology in medicine and beyond. Amar is driven by his passion for translating basic science discoveries into products that have a positive impact on society.
Prior to joining KV, Amar held various operating roles in strategy and business development at Arvinas and Triplet Therapeutics. Amar also has several years of experience working as a management consultant at LEK Consulting, advising leading biotechnology and pharmaceutical companies on strategic planning, M&A, R&D, and business development strategy.
Amar received his Ph.D. in Biological Engineering from MIT, where he was funded by DARPA to develop novel synthetic biology tools for therapeutic, industrial, and food engineering applications. He holds several patents for genome engineering techniques.
20+Co-authored peer-reviewed scientific publications